Cell cycle arrest in a model of colistin nephrotoxicity

Physiological Genomics - Tập 45 Số 19 - Trang 877-888 - 2013
Michael T. Eadon1, Bradley K. Hack2, Jessy J. Alexander3, Chang Xu2, M. Eileen Dolan4, Paul Cunningham2
1Divisions of Nephrology and Clinical Pharmacology, Indiana University, Indianapolis, Indiana;
22Section of Nephrology,
34Department of Medicine, University at Buffalo, Buffalo, New York
43Section of Hematology/Oncology, University of Chicago, Chicago, Illinois; and

Tóm tắt

Colistin (polymixin E) is an antibiotic prescribed with resurging frequency for multidrug resistant gram negative bacterial infections. It is associated with nephrotoxicity in humans in up to 55% of cases. Little is known regarding genes involved in colistin nephrotoxicity. A murine model of colistin-mediated kidney injury was developed. C57/BL6 mice were administered saline or colistin at a dose of 16 mg/kg/day in 2 divided intraperitoneal doses and killed after either 3 or 15 days of colistin. After 15 days, mice exposed to colistin had elevated blood urea nitrogen (BUN), creatinine, and pathologic evidence of acute tubular necrosis and apoptosis. After 3 days, mice had neither BUN elevation nor substantial pathologic injury; however, urinary neutrophil gelatinase-associated lipocalin was elevated ( P = 0.017). An Illumina gene expression array was performed on kidney RNA harvested 72 h after first colistin dose to identify differentially expressed genes early in drug treatment. Array data revealed 21 differentially expressed genes (false discovery rate < 0.1) between control and colistin-exposed mice, including LGALS3 and CCNB1. The gene signature was significantly enriched for genes involved in cell cycle proliferation. RT-PCR, immunoblot, and immunostaining validated the relevance of key genes and proteins. This murine model offers insights into the potential mechanism of colistin-mediated nephrotoxicity. Further studies will determine whether the identified genes play a causative or protective role in colistin-induced nephrotoxicity.

Từ khóa


Tài liệu tham khảo

10.1289/ehp.6683

Banfi G, 1985, Q J Med, 55, 153

10.1080/00365510802145059

10.1099/00221287-59-2-263

10.1186/1471-2105-8-412

10.1681/ASN.2004090740

10.1177/41.1.7678022

10.1038/clpt.2011.48

10.2217/pgs.10.37

10.1046/j.1523-1755.2001.060003900.x

10.3109/15376516.2012.754533

10.1097/TP.0b013e318242f40a

10.1128/AAC.8.1.50

10.1128/AAC.01707-09

10.1152/ajprenal.00023.2012

10.1345/aph.18426

10.1186/cc3995

10.1038/sj.onc.1207116

10.1038/349132a0

Gudowski G, 1970, Dtsch Gesundheitsw, 25, 2349

Hakim A, 2008, Med Sci Monit, 14, BR74

10.1086/599225

10.1016/S1097-2765(00)80002-7

10.1016/j.jacc.2012.04.053

10.1152/ajprenal.00151.2010

10.1152/ajprenal.00507.2010

10.1093/nar/gkn923

10.1038/nprot.2008.211

10.1096/fj.04-2031fje

10.1152/ajprenal.00435.2004

10.1186/1471-2105-7-359

10.1186/cc12503

Kim HR, 1999, Cancer Res, 59, 4148

10.1016/j.ijantimicag.2009.06.028

10.1159/000320746

10.1038/ki.2008.499

10.1016/j.ijantimicag.2009.12.002

10.1093/jac/dkh167

10.1128/AAC.47.5.1766-1770.2003

10.1016/j.ijantimicag.2004.10.001

10.1016/S1473-3099(06)70580-1

10.1111/j.1365-2885.2005.00666.x

10.1093/carcin/21.11.1941

10.1128/AAC.00030-09

10.1093/jac/dkq183

10.1152/ajprenal.00078.2002

10.1172/JCI1497

10.1111/j.1523-1755.2004.00927.x

Nepal M, 2008, Ann Clin Lab Sci, 38, 210

10.1016/S0002-9440(10)64595-6

10.1172/JCI118291

10.1152/ajprenal.00326.2010

10.1093/jac/dkq069

10.1016/S0270-9295(03)00087-1

10.1038/ki.2009.224

10.1096/fj.01-0006com

10.1038/ki.2010.463

10.1080/00365540903147001

10.2146/ajhp060501

10.1016/j.tcb.2009.10.002

10.1161/CIRCHEARTFAILURE.112.000129

10.1128/AAC.01101-07

Wang D, 2009, PDA J Pharm Sci Technol, 63, 159

10.1152/ajprenal.00089.2009

10.1101/gad.12.14.2131

10.1038/nm.2144

10.1093/jac/dkr483

10.1128/AAC.00328-11

10.1152/ajprenal.00101.2005

Thông tin
Thông tin xuất bản

Physiological Genomics

Tập 45 Số 19

877-888

Thông tin tác giả